J&J, HRSA at Loggerheads Over 340B Drug Pricing for Stelara and Xarelto

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-26T08:36:39-04:00August 26th, 2024|Latest News|0 Comments

Pharmacists, Pharmacy Benefit Managers, argue over high drug, business costs at hearing

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-26T08:35:38-04:00August 26th, 2024|Latest News|0 Comments

Transparency will unlock a sustainable pharmaceutical future

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-26T08:34:48-04:00August 26th, 2024|Latest News|0 Comments

Medical costs could rise due to Houston Healthcare merger, researcher says

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-26T08:33:27-04:00August 26th, 2024|Latest News|0 Comments

Biosimilar Uptake In The US: Patient And Prescriber Factors

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-23T09:20:47-04:00August 23rd, 2024|Latest News|0 Comments

The Role Of Financial Incentives In Biosimilar Uptake In Medicare: Evidence From The 340B Program

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-23T09:19:39-04:00August 23rd, 2024|Latest News|0 Comments

Healthcare employers await FTC’s next move on noncompete clauses

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-23T09:13:52-04:00August 23rd, 2024|Latest News|0 Comments

More Employers Turning to Benefit Startups to Manage Drug Costs

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-23T09:13:12-04:00August 23rd, 2024|Latest News|0 Comments

Why one health system thinks its new PBM can disrupt the market

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-23T09:10:17-04:00August 23rd, 2024|Latest News|0 Comments

Insurance brokers face increased pressure to deliver affordable costs

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-23T09:09:28-04:00August 23rd, 2024|Latest News|0 Comments